Currently out of the existing stock ratings of James Gordon, 45 are a BUY (43.27%), 51 are a HOLD (49.04%), 8 are a SELL (7.69%).

James Gordon

Work Performance Price Targets & Ratings Chart

Analyst James Gordon, currently employed at BARCLAYS, carries an average stock price target met ratio of 62.14% that have a potential upside of 26.63% achieved within 196 days.

James Gordon’s has documented 186 price targets and ratings displayed on 13 stocks. The coverage is on Healthcare, Financial Services, Basic Materials, Consumer Defensive, Technology sectors.

Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 06-Jan-2026.

Wall Street Analyst James Gordon

Analyst best performing recommendations are on ALC (ALCON AG).
The best stock recommendation documented was for ALC (ALCON AG) at 4/10/2019. The price target of $55 was fulfilled within 1 day with a profit of $1.41 (2.5%) receiving and performance score of 25.

Average potential price target upside

of $100.62 (23.21%) on ARGX (ARGENX NV ADR).
of $33.27 (28%) on AZN (ASTRAZENECA PLC ADR).
of $10.31 (30.52%) on AB (ALLIANCEBERNSTEIN HOLDING L.P.).

ALC Alcon AG ARGX argenx NV ADR GLPG Galapagos NV ADR GMAB Genmab AS GSK GlaxoSmithKline PLC ADR GRFS Grifols SA ADR MOR MorphoSys AG ADR AZN AstraZeneca PLC ADR ABCM Abcam PLC AB AllianceBernstein Holding L.P. HL Hecla Mining Company MO Altria Group ON ON Semiconductor

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Anthony Petrone (MIZUHO)